Legal Representation
Attorney
Alexandra MacKay
USPTO Deadlines
Next Deadline
8 days remaining
Section 71 Declaration Due (Principal Register 66a) (Based on registration date 20191231)
Due Date
December 31, 2025
Grace Period Ends
June 30, 2026
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
27 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Dec 31, 2024 | REM3 | E | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | Loading... |
| May 8, 2020 | FINO | P | FINAL DECISION TRANSACTION PROCESSED BY IB | Loading... |
| Apr 16, 2020 | FICS | P | FINAL DISPOSITION NOTICE SENT TO IB | Loading... |
| Apr 16, 2020 | FIMP | P | FINAL DISPOSITION PROCESSED | Loading... |
| Mar 31, 2020 | FICR | P | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | Loading... |
| Dec 31, 2019 | R.PR | A | REGISTERED-PRINCIPAL REGISTER | Loading... |
| Oct 15, 2019 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Oct 15, 2019 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Oct 12, 2019 | GPNX | P | NOTIFICATION PROCESSED BY IB | Loading... |
| Sep 25, 2019 | OPNS | P | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | Loading... |
| Sep 25, 2019 | OP2R | P | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | Loading... |
| Sep 25, 2019 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Sep 12, 2019 | ALIE | A | ASSIGNED TO LIE | Loading... |
| Sep 11, 2019 | CNSA | O | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Sep 10, 2019 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Sep 9, 2019 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Sep 9, 2019 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Apr 6, 2019 | RFNT | P | REFUSAL PROCESSED BY IB | Loading... |
| Mar 21, 2019 | RFCS | P | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | Loading... |
| Mar 21, 2019 | RFRR | P | REFUSAL PROCESSED BY MPU | Loading... |
| Mar 15, 2019 | MAFR | O | APPLICATION FILING RECEIPT MAILED | Loading... |
| Mar 13, 2019 | RFCR | E | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | Loading... |
| Mar 12, 2019 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Mar 11, 2019 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Mar 11, 2019 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Mar 8, 2019 | LIMI | I | LIMITATION FROM ORIGINAL APPLICATION ENTERED | Loading... |
| Feb 28, 2019 | REPR | M | SN ASSIGNED FOR SECT 66A APPL FROM IB | Loading... |
Detailed Classifications
Class 005
Vaccines; immune modulators, namely, pharmaceutical preparations for treatment of immune system related diseases, disorders, and dysregulation; vitamins and vitamin preparations
Class 042
Scientific and technological services and research and design relating thereto, namely, research and development in the pharmaceutical and biotechnology fields; scientific and industrial analysis and research services, namely, research relating to immune system related diseases and disorders; clinical research in the field of medical science, namely, medical and scientific research in the nature of conducting clinical trials; research and development services in the fields of drug discovery, drug discovery products, pharmaceuticals, medicinal diagnostics, biological products, medical apparatus, devices and instruments, namely, pharmaceutical drug development services; supply of information in the area of laboratory technology, namely, providing technology information in the medical diagnostic industry; medical laboratory services; provision of scientific information via Internet portals, namely, providing scientific information in the field of immunotherapy products in the nature of pharmaceutical preparations for the treatment of immune system related disease, disorder, and dysregulation; scientific consultancy, namely, consulting services in the field of the research and development of immunotherapy products in the nature of pharmaceutical preparations for the treatment of immune system related disease, disorder, and dysregulation; consultancy and research in the fields of science and technology, namely, research in the pharmaceutical and biotechnology fields; laboratory analysis and diagnostic services, namely, laboratory services in the nature of analysis and diagnosis of immune dysregulation; technical consultation and research in the fields of biotechnology and drug discovery; product research and development; providing databases in the fields of science and technology, namely, providing an on-line computer database in the field of medical and scientific research of immune dysregulation
Class 044
Medical and therapeutic services, namely, treatment of patients with immuno disorders; medical, hygienic and beauty care for human beings; provision of medical information; advisory services relating to medical services, preparations and apparatus, namely, providing medical information, consultancy and advisory services; providing information and advice in the field of healthcare; providing databases and information in the field of health, namely, providing an on-line computer database featuring information regarding health and nutrition
Additional Information
Design Mark
The mark consists of the stylized wording "IMMODULON", where "IMM" is in white and surrounded by a shaded teal circle and "ODULON" is in dark blue. All other instances of the color white in the mark represent background and/or transparent areas only and are not claimed as features of the mark.
Color Claim
The color(s) dark blue, teal, and white is/are claimed as a feature of the mark.
Classification
International Classes
005
042
044